Missing/wrong data?
Log in to edit
Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value?
scientific article published in October 2007
Author/s
author: Rebecca Miksad
Work details
Publication date
October 1, 2007
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.